Business Context and Reporting Period
Company: SONO-TEK CORP
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: November 30, 1998
Business Overview: Sono-Tek manufactures spray systems, including the SonoFlux System, Nozzle Systems, and newer products like the MCS Infinity System and Liquid Delivery Systems. The company is actively diversifying its product line to reduce dependence on the electronics industry.
Key Financial Metrics
| Metric | Nine Months Ended Nov 30, 1998 | Nine Months Ended Nov 30, 1997 | Three Months Ended Nov 30, 1998 | Three Months Ended Nov 30, 1997 |
|---|---|---|---|---|
| Net Sales | $2,395,727 | $2,588,626 | $679,428 | $1,013,198 |
| Gross Profit | $1,103,787 | $1,318,432 | $296,475 | $519,395 |
| Gross Margin % | 46.1% | 51.0% | 43.6% | 51.3% |
| Operating Loss | $(169,030) | $194,600 | $(104,185) | $97,516 |
| Net Loss | $(201,053) | $157,436 | $(109,890) | $85,616 |
| EPS (Basic) | $(0.05) | $0.04 | $(0.03) | $0.02 |
| Cash and Equivalents (Nov 30, 1998) | $16,276 | |||
| Working Capital (Nov 30, 1998) | $498,079 | |||
| Total Debt (Current + Long Term) | $730,188 |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 7.5% for the nine-month period and 33% for the three-month period compared to the prior year. The decline is primarily attributed to a slowdown in the electronics industry affecting SonoFlux System sales and a significant drop in Nozzle System sales.
- Profitability Reversal: The company shifted from a net profit of $157,436 in the prior nine-month period to a net loss of $201,053. This was driven by lower sales volume and increased operating expenses.
- Expense Increases: Research and product development costs rose by $98,051 (nine months) due to expanded engineering staff. General and administrative costs increased by $61,578 due to higher compensation and professional fees.
- Liquidity Deterioration: Cash and cash equivalents dropped from $113,759 to $16,276. Working capital decreased by $193,256, and stockholders' equity fell by $199,733 due to accumulated losses.
Guidance, Outlook, and Risks
- Outlook: Management expects SonoFlux sales to recover when the electronics assembly industry returns to growth. New products (MCS Infinity and Liquid Delivery Systems) are gaining traction, now accounting for over 8% of total sales.
- Liquidity Strategy: The company relies on a $150,000 revolving line of credit and anticipates that current working capital and credit availability will suffice for the next twelve months. Management has applied to increase the line of credit.
- Year 2000 (Y2K) Risk: The company identified non-compliant accounting software and internal network components. It has ordered upgrades with a target completion date of February 28, 1999. Total estimated cost is $25,000 ($15,000 spent to date). No contingency plan has been developed yet.
- Market Risks: The company faces risks related to general economic conditions, competition, and the ability to enforce patents. Sales of Nozzle Systems are volatile and dependent on marketing effectiveness.
Investor Verification Checklist
- Cash Runway: Verify if the $16,276 cash balance and $150,000 credit line are sufficient to cover operations given the current burn rate and net loss trajectory.
- Debt Covenants: Review the terms of the revolving line of credit and long-term debt to ensure no covenants are breached due to the decline in working capital or equity.
- Y2K Implementation: Confirm the successful installation and testing of Y2K-compliant software and hardware by the February 28, 1999 deadline.
- Product Mix Shift: Monitor the growth rate of new products (MCS Infinity, Liquid Delivery) to determine if they can offset the decline in legacy SonoFlux and Nozzle System sales.
- Inventory Levels: Assess the $836,105 inventory balance against the declining sales trend to identify potential obsolescence risks.